Halaven

Eribulin mesylate · BSP Pharmaceuticals SpA
CANCER MEDICINE · PRESCRIPTION ONLY (USA)

Halaven ingredients

Active ingredientStrength
Eribulin Mesylate1 mg/2mL, .5 mg/mL

What Halaven is used for

The FDA lists the approved uses on the official label (below). In the EU, eribulin is approved as Halaven for:

Halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5.1). Prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments. Halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5.1).

EU wording from the European Medicines Agency; US approved uses can differ.

Key facts

Brand
Halaven
Generic name
Eribulin mesylate
Made by
BSP Pharmaceuticals SpA
Forms
Injection
Given
Intravenous
Drug class
Microtubule Inhibitor
FDA approval
New drug application (NDA) NDA201532
On the US market since
2010

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Halaven?

Halaven (Eribulin mesylate) is a cancer medicine made by BSP Pharmaceuticals SpA, approved by the US FDA.

What are the ingredients of Halaven?

Halaven contains Eribulin Mesylate (1 mg/2mL, .5 mg/mL).

Is Halaven approved in Europe?

The same active substance is approved in the EU as Halaven.

From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.